| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |